Vanta Bioscience through its step down subsidiary -- Vayam Research Solutions has entered into a non-exclusive CRO Service Agreement with Emcure Pharmaceuticals, Pune, for providing services of Bio-Analytical and Bio-Equivalence services to the said company for a period of three years from 2019 to 2022.
The CRO Service Agreement provides for a minimum revenue assurance between Rs 7 crore to Rs 9 crore for the financial year 2019-2020 and Rs 20 crore for financial year 2020-2021.
Vanta Bioscience is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.
| Company Name | CMP |
|---|---|
| Syngene Internation. | 482.50 |
| Indegene | 542.65 |
| CMS Info Systems | 293.55 |
| JITF Infralogistics | 314.00 |
| Sagility | 45.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: